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Gag proteins underlie retroviral replication by fulfilling numerous functional roles at
various stages during viral life cycle. Out of the four mature proteins, Gag-capsid (CA)
is a major component of viral particles, and has been most well studied biogenetically,
biochemically and structurally. Gag-CA is composed of two structured domains, and
also of a short stretch of disordered and flexible interdomain linker. While the two
domains, namely, N-terminal and C-terminal domains (NTD and CTD), have been the
central target for Gag research, the linker region connecting the two has been poorly
studied. We recently have performed systemic mutational analyses on the Gag-CA
linker region of HIV-1 by various experimental and in silico systems. In total, we have
demonstrated that the linker region acts as a cis-modulator to optimize the Gag-related
viral replication process. We also have noted, during the course of conducting the
research project, that HIV-1 and SIVmac, belonging to distinct primate lentiviral lineages,
share a similarly biologically active linker region with each other. In this brief article, we
summarize and report the results obtained by mutational studies that are relevant to
the functional significance of the interdomain linker of HIV/SIV Gag-CA. Based on this
investigation, we discuss about the future directions of the research in this line.
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INTRODUCTION
Gag is a main viral protein initially synthesized as a precursor in cells infected with retroviruses
(Freed and Martin, 2013; Goff, 2013). Gag precursors then multimerize at the plasma membrane
(PM) to form immature virus particles with other viral and cellular components, followed by their
extracellular release and final maturation via processing by viral protease (Freed and Martin, 2013;
Goff, 2013). Although much about those events remains to be mechanistically elucidated, correct
assembly of precursor Gag proteins in cells and the subsequent proper maturation at the final stage
are certainly prerequisites for the generation of retroviral infectious virions and for the next round
of successful productive infection in target cells. HIV-1 Gag-CA mutants that form aberrant capsid
core or with defects in virus production simultaneously exhibit a severe reduction in the early viral
infectivity (von Schwedler et al., 2003; Chang et al., 2007; Jiang et al., 2011; Robinson et al., 2014;
Tanaka et al., 2016; Koma et al., 2019). Gag-CA, mainly consisting of structured NTD and CTD,
plays a major role in the above processes, and thus is essential for both early and late viral replication
phases. It is well established from extensive mutational and structural studies that HIV-1 Gag-CA
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carries out its pivotal functions in a sophisticatedly regulated
way (Sundquist and Kräusslich, 2012; Bell and Lever, 2013;
Lingappa et al., 2014; Campbell and Hope, 2015; Freed, 2015;
Mattei et al., 2016).
Assembly of immature precursor Gag proteins in cells is
mainly driven by their Gag-CA domain. Following synthesis
in the cytoplasm, the precursors gradually multimerize in
due course. Recent structural studies on the immature HIV-
1 Gag-CA have demonstrated that intra-hexameric NTD-CTD,
inter-hexameric NTD-NTD, inter-hexameric CTD-CTD, and
intra-hexameric CTD-CTD contacts can be formed during the
assembly (Bharat et al., 2012, 2014; Schur et al., 2015, 2016). Of
note, mutations that cause the defect in virus production resided
within or adjacent to the Gag-CA contact sites described above.
Thus, it can be concluded that various amino acid residues and/or
regions in both CA-NTD and CA-CTD are critical for the Gag
assembly and subsequent virus particle production.
While much is known about the role and activity of CA-
NTD and CA-CTD as described above, research reports on the
interdomain linker region itself was limited (Arvidson et al.,
2003; Jiang et al., 2011). Some studies on a serine residue in
the linker region (amino acid number 149 for HIV-1 Gag-CA)
were conducted (Cartier et al., 1999; Wacharapornin et al., 2007;
Brun et al., 2008; Takeuchi et al., 2017), mainly because it is
a major phosphorylation site in HIV-1 Gag-CA. Totally, it was
quite unclear how important or critical the interdomain linker
region of HIV-1 Gag-CA is for Gag assembly, virus production,
and viral early infectivity. Thus, much remains to be clarified
about the role for the CA-linker region in virus replication cycle.
In this report, we sort out important functional and structural
information on the interdomain linker region of HIV/SIV Gag-
CA published so far, and enrich the discussion by summarizing
our new report just published (Koma et al., 2019) and by adding
new relevant data on the corresponding CA-linker mutants of a
standard SIVmac clone.
COMPARISON OF AMINO ACID
SEQUENCES IN THE LINKER REGION
OF SIVMAC AND HIV-1 GAG-CA
PROTEINS
We recently have analyzed the interdomain linker region of HIV-
1 Gag-CA in detail (Koma et al., 2019). The amino acid sequence
of the region is SPTSI (Figure 1A), and as reported (Koma
et al., 2019), is remarkably well conserved among HIV-1 isolates
(98.9 to 99.9% for each residue in subtype B viruses and 97.5
to 99.9% in group M viruses) except for the T residue in the
middle (amino acid numbers 146 and 148 for SIVmac MA239N
and HIV-1 NL4-3 numbering systems, respectively) (64.1% for
subtype B viruses and 31.6% for group M viruses). The fact
that the T residue is significantly more conserved for subtype
B viruses than for group M viruses may imply that the “SPTSI”
sequence emerged following inter-species transmission of SIVcpz
to humans. In fact, only CPVGI, CPVSI, SPASI, and SPVSI are
identified in the SIVcpz sequences (sequences of 13 clones listed
in the HIV-1/SIVcpz Proteins of the HIV Sequence Compendium
20091 and 20182). The corresponding sequence of SIVmac Gag-
CA (NPTNI in Figure 1A) was also conserved well (93.2 to 98.6%
for each residue) (sequences of 74 clones listed in the HIV-2/SIV
Proteins of the HIV Sequence Compendium 2018; see footnote
2). Although not so drastic when compared with the HIV-1 linker,
we noted that the frequency of the T residue at the 146th position
is relatively lower (93.2%) than those of the amino acids at the
other positions (97.3 to 98.6%). Interestingly, most of the 3rd
amino acid in the linker region is T or V residue: 89.6% for HIV-1
subtype B and 94.9% for HIV-1 group M; 97.3% for HIV-2/SIV.
Another point worth mentioning about the HIV-1 Gag-linker
here is that different effects of amino acid types substituted at
the 149th position (147th for SIVmac Gag) on HIV-1 replication
properties (Koma et al., 2019). Mutant S149N could grow albeit
poorly in target lymphocytic cells, but mutants S149A, S149D,
and S149K did not grow at all. Consistently, S149N exhibited
normal early single-cycle infectivity in indicator cells but was
partially defective for virus production (late replication phase).
S149A, S149D, and S149K were severely defective or negative for
the early infectivity and viral particle production. Thus, the S to
N substitution at the 149th position (147th for SIVmac239 in
Figure 1A) only gave a mild mutational effect, and S149N showed
a less attenuated phenotype than S149A, S149D, and S149K. The
results on viral replication properties obtained for mutants S149N
and S149A (Koma et al., 2019) are summarized at the bottom of
Figure 1B. While S149A was very attenuated (∼12% and ∼6%
relative to wild-type NL4-3 for the virion production and single-
cycle infectivity, respectively), S149N considerably or comparably
retained the viral activities (∼46% virion production and ∼99%
single-cycle infectivity of NL4-3) (Koma et al., 2019).
STRUCTURAL REGULATION OF HIV
GAG-CA FOR VIRAL REPLICATION BY
ITS INTERDOMAIN LINKER REGION
Molecular events for HIV-1 Gag-CA assembly are schematically
summarized in Figure 1B. In our recent work, we have
extensively characterized the interdomain linker mutants of HIV-
1 Gag-CA by various virological, biochemical, and molecular
biological methods (Koma et al., 2019) to see if and how the
mutations affect the assembly process using the virus production
level as a final outcome. Out of nine linker mutants analyzed,
eight were found to be defective for virus particle production,
to various degrees, from lymphocytic producer cells relative to
wild-type NL4-3. Some mutants were similarly deficient with
controls that are known not to produce virus particles (von
Schwedler et al., 2003; Robinson et al., 2014; Tanaka et al., 2016).
Together with the observation that Gag mutations affecting the
virus production have little effects on the expression in cells
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FIGURE 1 | Interdomain linker region of SIV/HIV Gag-CA proteins. (A) Amino acid residues in the Gag-CA linker region. Upper: the amino acid sequence alignment
of the Gag-CA region of SIVmac clone MA239N (Shibata et al., 1991; Doi et al., 2010, 2011) and HIV-1 clone NL4-3 (Adachi et al., 1986) that encompasses the helix
7 (H7), interdomain linker, helix 310H (Gres et al., 2015), major homology region (MHR), and H8. Amino acids in the SIVmac Gag-CA linker region are highlighted by
bold letters. In addition, the amino acid site into which mutations were introduced in this study is indicated by red letters. Amino acid numbers are those for
SIVmac239 (GenBank: M33262). Lower: the frequencies of amino acids at numbers 144 to 148 (the linker region of HIV-2/SIV) for various HIV-2/SIVs. These Data
are based on the sequences of 74 clones listed in the HIV-2/SIV Proteins of the HIV Sequence Compendium 2018 (https://www.hiv.lanl.gov/content/sequence/HIV/
COMPENDIUM/2018/sequence2018.pdf). (B) Intracellular assembly process of HIV-1 Gag precursor protein and replication phenotypes of relevant HIV-1NL4−3
linker mutants. Major function for each of the four Gag domain is also shown on the left. HIV-1 Gag assembly process in cells is schematically shown. Previously
reported phenotypes of the HIV-1 interdomain linker mutants designated S149N and S149A (Koma et al., 2019) are summarized at the bottom. S149A is more
attenuated than S149N as shown. S149A, ∼12% and ∼6% of wild-type NL4-3 for the virion production and single-cycle infectivity, respectively; S149N, ∼46% and
∼99% of NL4-3 for the virion production and single-cycle infectivity, respectively (Koma et al., 2019). MA, matrix protein; CA, capsid protein; NC, nucleocapsid
protein; p6, p6 protein; PM, plasma membrane.
or modulate the Gag assembly process. It was also evident
from the analyses and previous data that the linker mutants
with severely reduced early infectivity are unable to produce
morphologically normal virus particles (Jiang et al., 2011; Koma
et al., 2019). We next examined the linker mutants for the Gag-
targeting to the PM by biochemical (sucrose density gradient
centrifugation) and confocal microscopic analyses. As indicated
in Figure 1B, Gag-NC and Gag-MA mediates the Gag-viral
RNA binding and Gag-PM binding, respectively (Sundquist
and Kräusslich, 2012; Freed, 2015). Our experimental results
on this issue showed that the decrease in virus production
for the linker mutants is primarily due to the impaired Gag-
Gag interactions at PM, although they exhibit inefficient PM
binding and localization to some extent. Consistent with this
conclusion, the live-cell protein interaction analysis, NanoBRET
analysis, demonstrated that Gag proteins of virus production-
defective mutants (S149A, S149D, and I150A) are impaired with
interacting activity as negative control mutants (major homology
region (MHR) mutants K158A and Y164A), but not of
the mutants with normal or moderately defective phenotype
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(S146A, S146N, and S149N) with respect to virus production.
Whether the mutants with defects in the virion production show
dominant-negative effects on the normal replication process of
wild-type virus remains to be experimentally analyzed. This
information may be of value for potential therapeutic application
in future. In summary, our results strongly suggest that the
interdomain linker of HIV-1 Gag-CA modulate the Gag-Gag
interaction/Gag assembly at PM. However, it should be noted that
mutational effects of the region are relatively mild compared with
those of NTD and CTD (Koma et al., 2019).
Since the hydrophobic interplay is known to be a major factor
contributing to the protein-oligomerization (Janin et al., 1988;
Jones and Thornton, 1996; Chiti et al., 2003; Jacak et al., 2012),
we examined 3D distributions of hydrophobic patches on HIV-1
Gag-CA (Koma et al., 2019). We found that hydrophobic patches
along or besides CA-CA interfaces are present on immature Gag-
CA, and that their distribution is different between immature and
mature Gag-CA proteins. Taken together, it was suggested that
the hydrophobic patches may play important roles in both early
and late viral replication phases. We finally analyzed molecular
bases that underlie the activity of interdomain linker region
by in silico system (Koma et al., 2019). We were interested in
predicting how the region modulates the Gag assembly process.
Extensive molecular dynamics (MD) simulations of wild-type
(NL4-3) and mutant (linker mutants S146A, S149A, I150A, and
MHR mutant Y164A) Gag-CA proteins have indicated that the
linker region and MHR can remotely affect structural fluctuations
of immature and mature Gag-CA interaction surfaces (allosteric
regulation of HIV-1 Gag-CA structure).
REPLICATION PHENOTYPES OF SIV
GAG-CA LINKER MUTANTS
We recently have determined various phenotypes of the
interdomain linker mutants of HIV-1 Gag-CA, and proposed
the functional role of the linker region for viral replication
(Koma et al., 2019). The phenotypes of the linker mutants can be
summarized as follows: (i) progeny virus production is markedly
or moderately reduced; (ii) viral early infectivity is considerably
or drastically impeded; (iii) progression of Gag multimerization
at PM is impaired while certain amounts of membrane-bound
Gag accumulates; (iv) mutational effects are generally mild;
(v) mutational effects are site- and amino acid-dependent in
the linker region. For confirmative and comparative purpose,
it is of great value to determine the replication phenotype of
interdomain linker mutants of SIVmac Gag-CA. The results and
discussions described above point out important issues from the
general to the particular: functional details of the linker region for
Gag assembly and individual points related to viral mutational
assays. We focused here the amino acid residue N at position
147 (S at position 149 for HIV-1) (Figure 1A). We constructed
SIVmac proviral mutants N147S and N147A, and compared
their virological properties with those of corresponding HIV-
1 mutants S149N and S149A. As shown in Figure 2A, the
two SIVmac Gag-CA mutants grew very differently in macaque
M1.3S cells, quite similarly as reported for HIV-1 S149N and
S149A mutants in human H9 cells (Koma et al., 2019). Of note,
N147S (SIVmac) and S149N (HIV-1) were infectious, whereas
N147A (SIVmac) and S149A (HIV-1) were faintly infectious or
non-infectious. It is possible that the progeny virus populations
from N147S-infected cells contained revertants and/or mutants
with additional mutations. Although it is unlikely that such
infectious variants emerged and constituted a major population
in a short period of time as can be seen in Figure 2A, the
genomes of progeny viruses need to be analyzed to confirm this.
The abilities of the two SIVmac mutants to produce progeny
virus particles upon transfection were also different (Figure 2B).
Although statistically not significant, there was an obvious
difference between the results for the two mutants. Because
M1.3S cells are too fragile for transfection analysis, 293T cells
were used for the experiments instead. The 293T cells are very
sensitive to transfection assays, and can produce a considerable
amount of virus particles even for the mutants defective in
the virion production. Thus, we may have overestimated the
relatively poor ability of N147A to produce virus particles. In
fact, while viral early infectivity was similarly impaired for the
two mutants (Figure 2C), N147S grew much more efficiently
than N147A (Figure 2A). This result is certainly attributable
to the difference in virus-producing ability of the two mutant
viruses (Figure 2B), being essentially similar as observed for the
corresponding two HIV-1 mutant viruses (Figure 1B). Totally,
viral replication properties of HIV-1 and SIVmac mutants with
mutations in a specific and corresponding site in the interdomain
linker region were in parallel except for the infectivity (compare
the mutational effects on viral infectivity of S149N and N147S
in Figures 1B and 2C, respectively). As for this difference, it
is not unreasonable to assume that mature CA-CA interaction
surfaces of HIV-1 and SIVmac were differently influenced by each
linker mutation in each backbone Gag-CA sequence. In essence,
our results suggest that the linker region of the two viruses,
HIV-1 and SIVmac of different primate lentiviral lineages, has a
similarly important role for the Gag assembly process. Thus, the
interdomain linker may probably be evolutionarily conserved,
and is important region for Gag-related events, and finally for
viral replication.
CONCLUDING REMARKS
Major conclusion in this report is that the interdomain region
of primate lentivirus Gag-CA plays an important role for
viral replication. More decisively and accurately, the Gag-
linker region of HIV-1 and probably of SIVmac is a cis-acting
allosteric modulator of CA interacting surfaces. Experimental
and in silico evidence supports the notion that the linker
region optimizes Gag assembly, progeny virus production, and
viral early infectivity by remotely regulating various interactions
among CA-NTD and CA-CTD (Koma et al., 2019; this report). Of
note, the interdomain linker connecting two structured domains
of Hsp70, a totally distinct cellular protein from viral Gag-CA,
has been recently reported to act as a dynamic switch that
allosterically regulates the interaction between the two domains
(English et al., 2017).
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FIGURE 2 | Replication ability of SIVmac mutants with site-specific mutations in the Gag-CA linker region. (A) Growth kinetics of the linker mutants (N147S and
N147A) in rhesus macaque M1.3S cells. Input viruses including a wild-type MA239N clone, prepared from transfected 293T cells (Nomaguchi et al., 2014, 2016),
were inoculated into M1.3S cells (Doi et al., 2011), and infected cells were monitored for virus replication at intervals by virion-associated reverse transcriptase (RT)
(Willey et al., 1988; Nomaguchi et al., 2013) activity in the culture supernatants. Amounts of input viruses were normalized by RT. Infection condition: 1 × 104 RT
units/2 × 105 cells. Four independent infection experiments were performed, and representative results were presented (experiments 1 and 2). (B) Virus production
level in transfected 293T cells. Proviral DNA clones indicated (5 µg) were transfected into 293T cells as previously described (Nomaguchi et al., 2016), and on day 2
post-transfection, culture supernatants were collected for RT assays. Virus production level relative to that for wild-type clone (SIVmav239N) is shown. n = 3.
Statistical significance was determined by Welch’s t-test. ns, statistically not significant. P-values for each pair are indicated. (C) Early infectivity in TZM-bl cells of the
linker mutants. To determine viral infectivity, virus samples (2 × 103 RT units prepared from transfected 293T cells) were inoculated into TZM-bl cells (4 × 103 cells)
(Platt et al., 1998, 2009), and cell lysates were prepared for luciferase assays (Promega) on day 2 post-infection as previously described (Nomaguchi et al., 2016;
Koma et al., 2019). Infectivity relative to that of wild-type clone (SIVmac239N) is shown. n = 3. Statistical significance was determined by Welch’s t-test. ns,
statistically not significant. P-value for N147S vs. N147A is indicated. ∗∗, p < 0.01.
There are a number of scientific issues to be addressed. (i) The
disordered linker region is considered to remotely regulate the
overall structural dynamics and molecular interactions of Gag-
CA. Then, how the linker region can allosterically modulate the
dynamics of Gag-CA? It is possible that networks of hydrophobic
and hydrophilic interactions on CA surface influence the mobility
of amino acids away from the linker region. (ii) How does
the Gag-precursor multimerization start? Factor(s) involved in
the initiation process is not yet fully uncovered (Sundquist and
Kräusslich, 2012; Lingappa et al., 2014; Freed, 2015). This issue
should be definitively elucidated. (iii) The 3rd amino acid in
the linker region is relatively variable (mostly T or V residue).
What is the molecular basis for the variability? How advantageous
is it for viruses? The variability may be necessary to optimize
virus growth ability in the context of the backbone Gag-CA
sequence. (iv) The linker region is conserved among HIV/SIV
with respect to sequence and activity. Then, how about the
other retroviruses? Do viruses other than those of the retrovirus
family have this kind of allosteric regulation system? It is
also intriguing to test functional exchangeability of various
“disordered linker regions.” This would help to understand
mechanistic and biological basis for the linker domain in various
viral and non-viral proteins.
It is absolutely important, in terms of basic virology and
also of developing new anti-HIV drugs, to fully understand
the molecular mechanism for the Gag-CA linker’s action and
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determine viral and cellular factors involved in the relevant
process. Studies in this line are in progress in our laboratory.
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